Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Cancers|March 28, 2024
Characterization of Incidental Pathogenic Germline Findings Detected via ctDNA among Patients with Non-Small Cell Lung Cancer in a Predominantly Hispanic/Latinx PopulationEsha Vallabhaneni, Samuel A Kareff, Reagan M Barnett, et al.International Journal of Surgical Pathology|May 12, 2023
Patterns of Immunoreactivity with TTF-1 Antibodies 8G7G3/1 and SPT24 Suggest Distinct Immunoprofiles Between Most Pulmonary and Nonpulmonary Small Cell CarcinomasLaurence M Briski, Manju Aron, Jonathan I Epstein, et al.Cancers|June 12, 2026
Tarlatamab in Previously Treated Small Cell Lung Cancer: A Real-World Experience in a Predominantly Hispanic Population with CNS MetastasesSantiago Sucre, Chinmay Jani, Dan Morgenstern-Kaplan, et al.NPJ Breast Cancer|November 5, 2022
Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancerNeelima Vidula, Andrew Lipman, Shumei Kato, et al.Eclinicalmedicine|February 19, 2025
Evolving trends in lung cancer risk factors in the ten most populous countries: an analysis of data from the 2019 Global Burden of Disease StudyChinmay T Jani, Samuel A Kareff, Dan Morgenstern-Kaplan, et al.JCO Oncology Advances|January 6, 2025
Disparities in Utilization of Immune Checkpoint Inhibitor Therapy Among Older Patients With Advanced Non-Small Cell Lung Cancer: A SEER-Medicare AnalysisDanting Yang, Shama D Karanth, Hyung-Suk Yoon, et al.Journal of Thoracic Disease|November 18, 2024
Rethinking how mobile units can catalyze progress on lung cancer screening: a scoping review of what we have learnedShama D Karanth, Joel Divaker, Marissa Blair, et al.Breast Cancer Research and Treatment|September 20, 2024
Genomic and transcriptomic landscape of HER2-low breast cancerRani Bansal, Tolulope Adeyelu, Andrew Elliott, et al.Cancers|April 27, 2024
The Genomic, Transcriptomic, and Immunologic Landscape of HRAS Mutations in Solid TumorsSamuel A Kareff, Asaad Trabolsi, Harris B Krause, et al.The Oncologist|July 10, 2024
Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumorsDan Morgenstern-Kaplan, Samuel A Kareff, Asaad Trabolsi, et al.Pageof 4